Michael F. Cola - Oct 1, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher R. Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
4
Date filed
10/4/2021, 04:28 PM
Previous filing
Jul 2, 2021
Next filing
May 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +78.1K $0.00 78.1K Oct 1, 2021 Common Stock 78.1K $2.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of this stock option will immediately vest on the date that it is granted. If employment is terminated prior to the end of the calendar quarter in which the option was granted, the number of shares underlying such stock option that reflects the percentage of calendar days remaining in such calendar quarter after such employment termination date shall be forfeited and deemed cancelled.